Quick Answer
Roivant Sciences Ltd. reported Total Assets of $5.44 billion for fiscal year 2025.
Roivant Sciences Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $5.44B | -24.7% |
| 2024 | $7.22B | +202.2% |
| 2023 | $2.39B | -7.6% |
| 2022 | $2.59B | -0.2% |
| 2021 | $2.59B | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $5.23B | -9.8% | +3.2% |
| September 30, 2025 | $5.06B | -18.4% | +0.6% |
| June 30, 2025 | $5.03B | -22.5% | -7.4% |
| March 31, 2025 | $5.44B | -24.7% | -6.1% |
| December 31, 2024 | $5.79B | -20.8% | -6.7% |
| September 30, 2024 | $6.21B | +200.5% | -4.5% |
| June 30, 2024 | $6.50B | +204.0% | -10.1% |
| March 31, 2024 | $7.22B | +202.2% | -1.2% |
- Roivant Sciences Ltd. showed a decrease of -24.7% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, Roivant Sciences Ltd.’s total assets has grown by 109.9% (from $2.59 billion to $5.44 billion).
- The most recent figure is from Roivant Sciences Ltd.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: